Corvus Pharmaceuticals Inc
NASDAQ:CRVS

Watchlist Manager
Corvus Pharmaceuticals Inc Logo
Corvus Pharmaceuticals Inc
NASDAQ:CRVS
Watchlist
Price: 7.7 USD 2.94% Market Closed
Market Cap: 575m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of CRVS.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CRVS Intrinsic Value
Not Available
Base Case Scenario
Compare CRVS to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CRVS?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Corvus Pharmaceuticals Inc

Current Assets 66.9m
Cash & Short-Term Investments 65.7m
Receivables 346k
Other Current Assets 909k
Non-Current Assets 13.5m
Long-Term Investments 11.5m
PP&E 1.1m
Other Non-Current Assets 852k
Current Liabilities 8.1m
Accounts Payable 2m
Accrued Liabilities 6.1m
Non-Current Liabilities 632k
Other Non-Current Liabilities 632k
Efficiency

Free Cash Flow Analysis
Corvus Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Corvus Pharmaceuticals Inc

Revenue
0 USD
Operating Expenses
-38.9m USD
Operating Income
-38.9m USD
Other Expenses
23.8m USD
Net Income
-15.1m USD
Fundamental Scores

CRVS Profitability Score
Profitability Due Diligence

Corvus Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ROE is Increasing
Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
hidden
Profitability
Score

Corvus Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

CRVS Solvency Score
Solvency Due Diligence

Corvus Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
hidden
Solvency
Score

Corvus Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CRVS Price Targets Summary
Corvus Pharmaceuticals Inc

Wall Street analysts forecast CRVS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CRVS is 15.64 USD with a low forecast of 11.11 USD and a high forecast of 25.2 USD.

Lowest
Price Target
11.11 USD
44% Upside
Average
Price Target
15.64 USD
103% Upside
Highest
Price Target
25.2 USD
227% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Corvus Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CRVS is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CRVS Insider Trading
Buy and sell transactions by insiders